Skip to main content
OpenTrials
Completed

NCT Number: NCT06754410

Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination With Alpha Blockers: A Prospective Randomized Controlled Study

we investigate the Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination with Alpha Blockers in distal ureter stone

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Qena university hospital

Qina, Qena Governorate, 83523, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all adult patients with lower ureter stone less than 10 mm

Exclusion criteria

  • pregnant, solitary kidney, sensitivity to drugs

Treatment and study plan

Tamsulosin

Drug

group A take tamsulosin once daily

Cetirizine

Drug

give cetirizine once dailly

Cetirizine + Tamsulosin

Combination Product

both once daily

Placebo

Other

once dailly

Primary outcomes

  1. ureter stone free rate

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

South Valley University

Other

Registry information

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Dec 31, 2024
Registry last updated
Dec 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.